SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-15-000389
Filing Date
2015-01-16
Accepted
2015-01-16 16:29:44
Documents
1
Period of Report
2015-01-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3010615seth_relmada.html 3  
1 OWNERSHIP DOCUMENT f3010615seth_relmada.xml 3 4330
  Complete submission text file 0001213900-15-000389.txt   5762
Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Issuer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 E 93RD STREET, #20-B NEW YORK NY 10128
Business Address
SETH SANDESH (Reporting) CIK: 0001566175 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55347 | Film No.: 15532956